Prosecution Insights
Last updated: September 17, 2026
Application No. 19/031,342

TISSUE ANCHOR DEPLOYMENT

Non-Final OA §112§DOUBLEPATENT
Filed
Jan 18, 2025
Priority
Oct 02, 2015 — provisional 62/236,225 +5 more
Examiner
RWEGO, KANKINDI
Art Unit
3771
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Harpoon Medical Inc.
OA Round
1 (Non-Final)
75%
Grant Probability
Favorable
1-2
OA Rounds
1y 4m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 75% — above average
75%
Career Allowance Rate
374 granted / 499 resolved
+4.9% vs TC avg
Strong +34% interview lift
Without
With
+33.9%
Interview Lift
resolved cases with interview
Typical timeline
3y 0m
Avg Prosecution
23 currently pending
Career history
532
Total Applications
across all art units

Statute-Specific Performance

§101
0.6%
-39.4% vs TC avg
§103
43.3%
+3.3% vs TC avg
§102
23.5%
-16.5% vs TC avg
§112
25.5%
-14.5% vs TC avg
Black line = Tech Center average estimate • Based on career data from 499 resolved cases

Office Action

§112 §DOUBLEPATENT
DETAILED ACTION It is noted during an examiner-initiated interview held 8/12/26, applicant’s representative was unable to clarify to which structural element the term “carrier” referred (See attached Interview Summary). Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Priority Applicant’s claim for the benefit of a prior-filed application under 35 U.S.C. 119(e) or under 35 U.S.C. 120, 121, 365(c), or 386(c) is acknowledged. Applicant has not complied with one or more conditions for receiving the benefit of an earlier filing date under 35 U.S.C. 120 as follows: The later-filed application must be an application for a patent for an invention which is also disclosed in the prior application (the parent or original nonprovisional application or provisional application). The disclosure of the invention in the parent application and in the later-filed application must be sufficient to comply with the requirements of 35 U.S.C. 112(a) or the first paragraph of pre-AIA 35 U.S.C. 112, except for the best mode requirement. See Transco Products, Inc. v. Performance Contracting, Inc., 38 F.3d 551, 32 USPQ2d 1077 (Fed. Cir. 1994) The disclosure of the prior-filed application, Application No. 18/332,309, fails to provide adequate support or enablement in the manner provided by 35 U.S.C. 112(a) or pre-AIA 35 U.S.C. 112, first paragraph for one or more claims of this application. Claim 1 recites, “a carrier” in line 4. The prior-filed application, Application No. 18/332,309 fails to disclose a carrier. 18/332,309 also fails to disclose the concept of a carrier configured to linearly translate within the handle. Applicant has not pointed out where in the prior-filed application, claims 1- 7 in this application are supported, nor does there appear to be a written description of the claim limitation “a carrier configured to linearly translate within the handle” in the prior-filed application. See MPEP 2163.04. Accordingly, claims 1- 7 are not entitled to the benefit of the prior application. Drawings The drawings are objected to under 37 CFR 1.83(a). The drawings must show every feature of the invention specified in the claims. Therefore, the carrier in claim 1 must be shown or the feature(s) canceled from the claim(s). No new matter should be entered. Corrected drawing sheets in compliance with 37 CFR 1.121(d) are required in reply to the Office action to avoid abandonment of the application. Any amended replacement drawing sheet should include all of the figures appearing on the immediate prior version of the sheet, even if only one figure is being amended. The figure or figure number of an amended drawing should not be labeled as “amended.” If a drawing figure is to be canceled, the appropriate figure must be removed from the replacement sheet, and where necessary, the remaining figures must be renumbered and appropriate changes made to the brief description of the several views of the drawings for consistency. Additional replacement sheets may be necessary to show the renumbering of the remaining figures. Each drawing sheet submitted after the filing date of an application must be labeled in the top margin as either “Replacement Sheet” or “New Sheet” pursuant to 37 CFR 1.121(d). If the changes are not accepted by the examiner, the applicant will be notified and informed of any required corrective action in the next Office action. The objection to the drawings will not be held in abeyance. Specification The specification is objected to as failing to provide proper antecedent basis for the claimed subject matter. See 37 CFR 1.75(d)(1) and MPEP § 608.01(o). Correction of the following is required: Claim 1 recites, “a carrier” in line 4. The specification fails to disclose a carrier. The specification also fails to disclose the concept of a carrier configured to linearly translate within the handle. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 1- 7 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claim 1 recites “a carrier” throughout the claim. After carefully reviewing the drawings and specification and calling applicant’s representative (See attached Interview Agenda), the examiner and applicant’s representative cannot specify or clarify as to what structural element the carrier refers. As such, the scope of claim 1 is unclear. Claims 2- 7 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being dependent off claim 1. Double Patenting The nonstatutory double patenting rejection is based on a judicially created doctrine grounded in public policy (a policy reflected in the statute) so as to prevent the unjustified or improper timewise extension of the “right to exclude” granted by a patent and to prevent possible harassment by multiple assignees. A nonstatutory double patenting rejection is appropriate where the conflicting claims are not identical, but at least one examined application claim is not patentably distinct from the reference claim(s) because the examined application claim is either anticipated by, or would have been obvious over, the reference claim(s). See, e.g., In re Berg, 140 F.3d 1428, 46 USPQ2d 1226 (Fed. Cir. 1998); In re Goodman, 11 F.3d 1046, 29 USPQ2d 2010 (Fed. Cir. 1993); In re Longi, 759 F.2d 887, 225 USPQ 645 (Fed. Cir. 1985); In re Van Ornum, 686 F.2d 937, 214 USPQ 761 (CCPA 1982); In re Vogel, 422 F.2d 438, 164 USPQ 619 (CCPA 1970); In re Thorington, 418 F.2d 528, 163 USPQ 644 (CCPA 1969). A timely filed terminal disclaimer in compliance with 37 CFR 1.321(c) or 1.321(d) may be used to overcome an actual or provisional rejection based on nonstatutory double patenting provided the reference application or patent either is shown to be commonly owned with the examined application, or claims an invention made as a result of activities undertaken within the scope of a joint research agreement. See MPEP § 717.02 for applications subject to examination under the first inventor to file provisions of the AIA as explained in MPEP § 2159. See MPEP § 2146 et seq. for applications not subject to examination under the first inventor to file provisions of the AIA . A terminal disclaimer must be signed in compliance with 37 CFR 1.321(b). The filing of a terminal disclaimer by itself is not a complete reply to a nonstatutory double patenting (NSDP) rejection. A complete reply requires that the terminal disclaimer be accompanied by a reply requesting reconsideration of the prior Office action. Even where the NSDP rejection is provisional the reply must be complete. See MPEP § 804, subsection I.B.1. For a reply to a non-final Office action, see 37 CFR 1.111(a). For a reply to final Office action, see 37 CFR 1.113(c). A request for reconsideration while not provided for in 37 CFR 1.113(c) may be filed after final for consideration. See MPEP §§ 706.07(e) and 714.13. The USPTO Internet website contains terminal disclaimer forms which may be used. Please visit www.uspto.gov/patent/patents-forms. The actual filing date of the application in which the form is filed determines what form (e.g., PTO/SB/25, PTO/SB/26, PTO/AIA /25, or PTO/AIA /26) should be used. A web-based eTerminal Disclaimer may be filled out completely online using web-screens. An eTerminal Disclaimer that meets all requirements is auto-processed and approved immediately upon submission. For more information about eTerminal Disclaimers, refer to www.uspto.gov/patents/apply/applying-online/eterminal-disclaimer. Application claims 8- 16 and 18- 20 are rejected on the ground of nonstatutory double patenting as being unpatentable over claims 1- 10 and 12 of U.S. Patent No. 12,201,342. Although the claims at issue are not identical, they are not patentably distinct from each other because Regarding application claim 8, application claim 8 is obvious in view of claim 1 of U.S. Patent No. 12,201,342. Regarding application claim 9, application claim 9 is obvious in view of claim 1 of U.S. Patent No. 12,201,342. Regarding application claim 10, application claim 10 is obvious in view of claim 2 of U.S. Patent No. 12,201,342. Regarding application claim 11, application claim 11 is obvious in view of claim 3 of U.S. Patent No. 12,201,342. Regarding application claim 12, application claim 12 is obvious in view of claim 4 of U.S. Patent No. 12,201,342. Regarding application claim 13, application claim 13 is obvious in view of claim 5 of U.S. Patent No. 12,201,342. Regarding application claim 14, application claim 14 is obvious in view of claim 6 of U.S. Patent No. 12,201,342. Regarding application claim 15, application claim 15 is obvious in view of claim 7 of U.S. Patent No. 12,201,342. Regarding application claim 16, application claim 16 is obvious in view of claim 8 of U.S. Patent No. 12,201,342. Regarding application claim 18, application claim 18 is obvious in view of claim 9 of U.S. Patent No. 12,201,342. Regarding application claim 19, application claim19 is obvious in view of claim 10 of U.S. Patent No. 12,201,342. Regarding application claim 20, application claim 20 is obvious in view of claim 12 of U.S. Patent No. 12,201,342. Application claims 8 and 17 are rejected on the ground of nonstatutory double patenting as being unpatentable over claim 13 of U.S. Patent No. 12,201,342. Although the claims at issue are not identical, they are not patentably distinct from each other because Regarding application claim 8, application claim 8 is obvious in view of claim 13 of U.S. Patent No. 12,201,342. Regarding application claim 17, application claim 8 is obvious in view of claim 13 of U.S. Patent No. 12,201,342. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to KANKINDI RWEGO whose telephone number is (303)297-4759. The examiner can normally be reached Monday- Friday: 10:00- 5:00 MT. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, (Jackie) Tan-Uyen Ho can be reached at 571 272-4696. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /KANKINDI RWEGO/Primary Examiner, Art Unit 3771
Read full office action

Prosecution Timeline

Jan 18, 2025
Application Filed
Aug 12, 2026
Examiner Interview (Telephonic)
Aug 20, 2026
Non-Final Rejection mailed — §112, §DOUBLEPATENT (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12733952
ATHERECTOMY SYSTEM ADAPTED TO ENABLE RETROGRADE ABLATION
4y 0m to grant Granted Sep 15, 2026
Patent 12733921
SOFT SURGICAL CONSTRUCT AND METHOD OF USE FOR TISSUE REPAIR
1y 11m to grant Granted Sep 15, 2026
Patent 12727898
MEDICAL SNARE
2y 11m to grant Granted Sep 08, 2026
Patent 12727899
AN INTRAVASCULAR DEVICE WITH AN IMPROVED ATTACHMENT OF ITS ELEMENTS AND A METHOD OF MANUFACTURING THEREOF
2y 2m to grant Granted Sep 08, 2026
Patent 12714451
DEVICES, SYSTEMS, AND METHODS FOR RETRIEVAL OF MATERIAL FROM VESSEL LUMENS
2y 4m to grant Granted Aug 25, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
75%
Grant Probability
99%
With Interview (+33.9%)
3y 0m (~1y 4m remaining)
Median Time to Grant
Low
PTA Risk
Based on 499 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month